These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35888001)

  • 1. Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Gjermeni D; Vetter H; Szabó S; Anfang V; Leggewie S; Hesselbarth D; Duerschmied D; Trenk D; Olivier CB
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35888001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time from blood draw to multiple electrode aggregometry and association with platelet reactivity.
    Hesselbarth D; Gjermeni D; Szabo S; Siegel PM; Diehl P; Moser M; Bode C; Olivier CB
    J Thromb Thrombolysis; 2023 Jan; 55(1):134-140. PubMed ID: 36344849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.
    Christ G; Siller-Matula JM; Francesconi M; Dechant C; Grohs K; Podczeck-Schweighofer A
    BMJ Open; 2014 Oct; 4(10):e005781. PubMed ID: 25361837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes.
    Jeong YH; Bliden KP; Shuldiner AR; Tantry US; Gurbel PA
    Thromb Haemost; 2014 Apr; 111(4):713-24. PubMed ID: 24336898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive values of post-clopidogrel platelet reactivity assessed by different platelet function tests on ischemic events in East Asian patients treated with PCI.
    Zhang HZ; Kim MH; Jeong YH
    Platelets; 2014; 25(4):292-9. PubMed ID: 23971791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
    Yao Y; Zhang JH; Tang XF; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Wang M; Gao RL; Yuan JQ
    Chin Med J (Engl); 2016 Oct; 129(19):2269-74. PubMed ID: 27647183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
    J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of high on-clopidogrel platelet reactivity in patients with acute coronary syndrome.
    Lee S; Hizoh I; Kovacs A; Horvath Z; Kiss N; Toth-Zsamboki E; Kiss RG
    Platelets; 2016; 27(2):159-67. PubMed ID: 26247099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.
    Aradi D; Tornyos A; Pintér T; Vorobcsuk A; Kónyi A; Faluközy J; Veress G; Magyari B; Horváth IG; Komócsi A
    J Am Coll Cardiol; 2014 Mar; 63(11):1061-70. PubMed ID: 24486281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.
    Kafian S; Mobarrez F; Wallén H; Samad B
    Platelets; 2015; 26(5):467-73. PubMed ID: 25025694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential ADP-stimulated light transmission and multiple electrode aggregometry in patients taking aspirin and clopidogrel after non ST-elevation myocardial infarction.
    Meen O; Brosstad F; Liestøl K; Kunszt G; Bendz B; Wettergreen M; Schjelderup NM; Andreassen T; Erikssen G
    Scand J Clin Lab Invest; 2012 Jul; 72(4):318-25. PubMed ID: 22724626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting.
    Rilinger J; Meyer M; Schnabel K; Weik P; Charlet A; Esser JS; Zhou Q; Bode C; Moser M; Diehl P; Olivier CB
    J Thromb Thrombolysis; 2016 Nov; 42(4):558-65. PubMed ID: 27387715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastography.
    Hou XM; Han WZ; Qiu XB; Fang WY
    Heart Asia; 2013; 5(1):66-9. PubMed ID: 27326080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty.
    Grifoni E; Gori AM; Giusti B; Valenti R; Migliorini A; Basili S; Paniccia R; Elmahdy MF; Pulli R; Pratesi C; Antoniucci D; Violi F; Marcucci R
    Eur J Vasc Endovasc Surg; 2018 Oct; 56(4):545-552. PubMed ID: 30025662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.
    Rubin GA; Kirtane AJ; Chen S; Redfors B; Weisz G; Baber U; Zhang Y; Stuckey TD; Witzenbichler B; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Ali ZA; Ben-Yehuda O; Stone GW
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):793-801. PubMed ID: 31721430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
    You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin.
    Siller-Matula JM; Delle-Karth G; Christ G; Neunteufl T; Maurer G; Huber K; Tolios A; Drucker C; Jilma B
    Int J Cardiol; 2013 Jul; 167(2):430-5. PubMed ID: 22305813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of individualized antiplatelet therapy based on CYP2C19 genotype and platelet function on the prognosis of patients after PCI.
    Zhang M; Wang JR; Zhang Y; Zhang P; Ren MY; Jia XM; Ma LP; Gao M; Hou YL
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10753-10768. PubMed ID: 33155236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.